Protagonist Therapeutics, Inc Proceeds from Issuance of Debt
Protagonist Therapeutics, Inc (PTGX) reported Proceeds from Issuance of Debt of $991.00 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2020-08-06
- Protagonist Therapeutics, Inc proceeds from issuance of debt for fiscal 2019 was $9.77M.
| Period end | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|
| 2020-06-30 | $991.00K 10-Q · filed 2020-08-06 | |
| 2019-12-31 | $9.77M 10-K · filed 2020-03-10 | |
| 2019-06-30 | $477.00K 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |